TTOO Accumulated Other Comprehensive Income from 2010 to 2024
| TTOO Stock | USD 0.47 0.01 1.04% |
Accumulated Other Comprehensive Income | First Reported 2013-12-31 | Previous Quarter -11 K | Current Value 0.0 | Quarterly Volatility 40.4 M |
Check T2 Biosystms financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among T2 Biosystms' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 4.9 M or Total Revenue of 9.8 M, as well as many indicators such as Price To Sales Ratio of 2.16, Dividend Yield of 0.0 or Days Sales Outstanding of 131. TTOO financial statements analysis is a perfect complement when working with T2 Biosystms Valuation or Volatility modules.
TTOO | Accumulated Other Comprehensive Income |
Latest T2 Biosystms' Accumulated Other Comprehensive Income Growth Pattern
Below is the plot of the Accumulated Other Comprehensive Income of T2 Biosystms over the last few years. It is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. T2 Biosystms' Accumulated Other Comprehensive Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in T2 Biosystms' overall financial position and show how it may be relating to other accounts over time.
| Accumulated Other Comprehensive Income | 10 Years Trend |
|
Accumulated Other Comprehensive Income |
| Timeline |
TTOO Accumulated Other Comprehensive Income Regression Statistics
| Arithmetic Mean | (2,968,200) | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | (121.84) | |
| Mean Deviation | 2,774,000 | |
| Median | (2,077,000) | |
| Standard Deviation | 3,616,596 | |
| Sample Variance | 13.1T | |
| Range | 11.3M | |
| R-Value | 0.28 | |
| Mean Square Error | 13T | |
| R-Squared | 0.08 | |
| Significance | 0.31 | |
| Slope | 226,429 | |
| Total Sum of Squares | 183.1T |
TTOO Accumulated Other Comprehensive Income History
About T2 Biosystms Financial Statements
T2 Biosystms investors utilize fundamental indicators, such as Accumulated Other Comprehensive Income, to predict how TTOO Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year |
Pair Trading with T2 Biosystms
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if T2 Biosystms position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in T2 Biosystms will appreciate offsetting losses from the drop in the long position's value.Moving together with TTOO Stock
Moving against TTOO Stock
| 0.93 | BMY | Bristol Myers Squibb | PairCorr |
| 0.9 | GILD | Gilead Sciences | PairCorr |
| 0.73 | ESPR | Esperion Therapeutics | PairCorr |
| 0.47 | DYAI | Dyadic International | PairCorr |
| 0.42 | DNA | Ginkgo Bioworks Holdings | PairCorr |
The ability to find closely correlated positions to T2 Biosystms could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace T2 Biosystms when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back T2 Biosystms - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling T2 Biosystms to buy it.
The correlation of T2 Biosystms is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as T2 Biosystms moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if T2 Biosystms moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for T2 Biosystms can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of T2 Biosystms Correlation against competitors. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.03) | Revenue Per Share 0.999 | Quarterly Revenue Growth (0.01) | Return On Assets (0.90) | Return On Equity (6.22) |
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.